Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg)
Sandwell and West Birmingham Hospitals NHS Trust
Fellow of Royal College of Surgeons, UK.
Doctorate of Medicine from Cranfield University, Silsoe, Bedfordshire.
MS from PGI Chandigarh, India.
Consultant Oncoplastic and Reconstructive Breast Surgeon at City Hospital Birmingham. UK
Director for Live Course for Chest Wall Perforator Flap for Partial Breast Reconstruction at City Hospital Birmingham.
Faculty for Breast Reconstruction Course at Keele University North Staffordshire.
Faculty for Advanced Skills in Breast Disease Management at Royal College of Surgeons London.
Faculty for TIG fellowship national meeting at Liverpool, UK.
Faculty for International Breast Reconstruction Course at AIIMS Delhi.
Faculty for CCrISP course, UK.
Mentoring Consultant Surgeons across UK for Partial Breast Reconstruction with CWPF flap.
Chest Wall Perforator Flaps for Partial Breast Reconstruction
Oncoplastic breast surgery has resulted in better aesthetic outcomes and quality of life as compared to conventional breast surgery. In small to medium sized breasts, volume replacement techniques would be indicated, especially in relatively larger tumours to avoid major deformity. Partial breast reconstruction using local perforator flaps ((LICAP/MICAP/AICAP) has increased its utility in such settings progressively over the last two decades. As a result, the indications for breast conserving surgery have expanded and mastectomy has been avoided in a selected number of patients with high tumour to breast ratio.
EVEN MORE SEMINARS
-
Professor Anthony Howell The University of Manchester / The Christie NHS Foundation Trust
Improving risk estimation of breast cancer
-
Dr Natalie Cook University of Manchester/Christie NHS Foundation Trust
Early phase trial options in prostate cancer
-
Chris Carrigan Bowel Cancer Intelligence UK
Patient Engagement in the uses of Patient Data
-
Dr Abeer Shaaban Queen Elizabeth Hospital Birmingham & University of Birmingham
Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations
-
Dr Qamar Ghafoor University Hospital Birmingham
Stereotactive Radiotherapy Treatment for Primary Lung Cancers, and Oligometastasis to the Lungs.
